Free Fatty Acid Metabolite Biomarkers for Cancer



Status:Completed
Conditions:Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 80
Updated:4/2/2016
Start Date:August 2012
End Date:August 2015
Contact:Daniel Sessler, M.D.
Email:ds@or.org
Phone:216-444-4900

Use our guide to learn which trials are right for you!

Surgical removal of tumor at an early stage remains the primary treatment for most cancers.
However, there is currently no reliable screening blood test for detection of lung, colon,
or breast cancer. The Specific Aims are to: 1) assess the diagnostic accuracy of six FFA
metabolites to detect lung and colon cancer in surgical patients; 2)determine the rate and
extent to which FFA metabolites decrease over time after surgery for lung and colon cancer;
and, 3)determine the positive and negative predictive values and overall test accuracy for
diagnostic prostate and breast biopsies.


Inclusion Criteria:

- potential breast cancer

- patients who have early stages of breast cancer prior to surgery potential prostate
cancer lung cancer colon cancer

Exclusion Criteria:

- 1) Patients will be excluded from enrollment if they have severe liver disease (ALT
three times the upper limit of normal). Patients will also be excluded who have taken
aspirin or COX inhibitors within 48 hours of surgery. 2) Patients will be excluded if
a pathologic diagnosis is already available,from a previous needle biopsy
(coordinator will remain blinded). 3) Patients will be excluded have received
pre-procedure chemotherapy or radiotherapy
We found this trial at
1
site
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials